Global Sourcing & Procurement

Newly FDA-Approved Products

Access newly FDA-approved US pharmaceutical innovations early — through a registered wholesaler with documentation-ready sourcing for international partners.

New US approvals create competitive windows for international distributors and specialty partners who can move quickly. McHade provides early access to newly FDA-approved products across priority therapeutic areas through licensed wholesaler channels.

Sourcing includes the documentation international partners need for regulatory filing and market entry — batch records, export paperwork, and supporting certificates where destination markets require them.

New approval sourcing complements tender support and named-patient programs — or stands alone when your market strategy depends on being among the first to offer a newly approved therapy.

Who it's for

Built for partners who need first-to-market access

  • International distributorsBring newly approved US therapies to your market ahead of competitors with documented supply.
  • Specialty pharmaceutical partnersAccess innovations in oncology, biologics, and rare disease through a registered US wholesaler.
  • Regional market entrantsBuild product portfolios around the latest FDA approvals with compliant sourcing support.

What's included

Scope and deliverables

  • Early access to newly approved US innovations
  • Wholesaler network access across priority therapeutic areas
  • Documentation-ready sourcing for international partners
  • Batch records and chain-of-custody for regulatory filing
  • Export paperwork, COO, and COA where destination markets require them
  • Coordination with warehousing, cold-chain, and export services as needed

How it works

How McHade delivers this service

A clear operating path from requirements review through documented cross-border delivery.

1

Identify the product

Confirm the newly approved product, therapeutic area, volumes, and destination market requirements.

2

Qualify supply channels

Locate licensed US availability and assess lead times against your market entry timeline.

3

Source & document

Procure with batch records and prepare export documentation for regulatory handoff.

4

Release & coordinate

Coordinate cross-border delivery with your clearing agent and local distribution partners.

Discuss Newly FDA-Approved Products

Share your product requirements, volumes, and destination markets. Our team will review the scope and respond with a compliant procurement approach — turnaround depends on product complexity and market requirements.